ClearPoint Neuro CLPT Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about ClearPoint Neuro's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ClearPoint Neuro's additional paid-in capital?
- ClearPoint Neuro (CLPT) reported additional paid-in capital of $239.47M in Q1 2026.
- How has ClearPoint Neuro's additional paid-in capital changed year-over-year?
- ClearPoint Neuro's additional paid-in capital increased by 10.3% year-over-year, from $217.1M to $239.47M.
- What is the long-term trend for ClearPoint Neuro's additional paid-in capital?
- Over 5 years (2020 to 2025), ClearPoint Neuro's additional paid-in capital has grown at a 14.4% compound annual growth rate (CAGR), from $121.73M to $239M.
- What does additional paid-in capital mean?
- This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.